GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » Revenue

Fonar (FONR) Revenue : $102.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 1981. Start your Free Trial

What is Fonar Revenue?

Fonar's revenue for the three months ended in Sep. 2024 was $25.0 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $102.0 Mil. Fonar's Revenue per Share for the three months ended in Sep. 2024 was $3.88. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $15.85.

Good Sign:

Fonar Corp has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Fonar was 4.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Fonar's highest 3-Year average Revenue per Share Growth Rate was 29.00% per year. The lowest was -31.80% per year. And the median was 2.20% per year.


Fonar Revenue Historical Data

The historical data trend for Fonar's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fonar Revenue Chart

Fonar Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.69 89.93 97.59 98.65 102.88

Fonar Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.84 25.39 25.72 25.94 24.96

Competitive Comparison of Fonar's Revenue

For the Diagnostics & Research subindustry, Fonar's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fonar's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fonar's Revenue distribution charts can be found below:

* The bar in red indicates where Fonar's Revenue falls into.



Fonar Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $102.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fonar  (NAS:FONR) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Fonar Revenue Related Terms

Thank you for viewing the detailed overview of Fonar's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fonar Business Description

Traded in Other Exchanges
Address
110 Marcus Drive, Melville, NY, USA, 11747
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
Executives
Timothy Raymond Damadian director, officer: CEO, President & Treasurer 110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni officer: Exec VP, COO & PFO 110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian director, officer: president 31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff director 32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O director 347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan director 145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry officer: Secretary BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian director 303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022

Fonar Headlines

From GuruFocus

Fonar: A Micro-Cap With 40% Upside

By Magic Diligence Magic Diligence 03-18-2015

Fonar Corp. Reports Operating Results (10-K)

By gurufocus 10qk 10-05-2009

Fonar Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 02-18-2011

Fonar Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-23-2009

Fonar Corp. Reports Operating Results (10-Q)

By gurufocus 02-18-2009